John Wiley & Sons, Inc. · NYSE:WLY

John Wiley & Sons — Q1 2027 Earnings Presentation

23 slides from John Wiley & Sons's earnings presentation, Sep 3, 2026

  1. Slide 1: Q1 2027 Earnings Review

    Q1 2027 Earnings Review SEPTEMBER 3, 2026 NYSE:WLY

  2. Slide 2: Safe Harbor Statement Non-GAAP Financial Measures

    SAFE HARBOR STATEMENT NON-GAAP FINANCIAL MEASURES This presentation contains certain forward-looking statements concerning the Wiley provides non-GAAP financial measures and performance results Company's operations, performance, and financial condition. Reliance should such as: not be placed on forw

  3. Slide 3: Trusted content and intelligence for the advancement of science and innovation

    Trusted content and intelligence for the advancement of science and innovation 3

  4. Slide 4: Q1 Takeaways Compounding Growth Engines

    Q1 Takeaways Compounding Growth Engines Research and AI momentum strong; results offset by prior year comparison and soft Learning demand in seasonally small Q 1 Durable, compounding Research growth engine • Delivered 12% increase in Research Publishing reflecting Emerald addition, AI momentum, and

  5. Slide 5: First Quarter 2027 performance as expected

    First Quarter 2027 performance as expected Strength in Research and AI offset by prior year comparison and softness in Learning Revenue* GAAP EPS Adj. EPS* Adj. EBITDA* ▼3% ▼$0.45 ▼10% ▼4% $386M ($0.23) $0.44 $68M ▪ Revenue performance driven by prior year AI licensing comparison headwind of $29 mil

  6. Slide 6: Continued strong progress in Research

    Continued strong progress in Research OBJECTIVE Q1 PROGRESS ▪ Submissions +31%, output +8% with strong demand across fast growing and mature markets, Drive high-quality publishing 01 throughput including China, India, US, Brazil, Japan, and the UK ▪ CY26 renewals closed; 99%+ retention ▪ Launched Ad

  7. Slide 7: Research momentum, accelerating

    Research momentum, accelerating Strong visibility and trends in global research productivity Robust publishing pipeline and scale advantage widening: Submissions and output Research Organic Growth 1 up 31% and 8%, outpacing market; researcher productivity rising with AI Mid-single 2 Solid calendar 2

  8. Slide 8: AI and data analytics growth initiatives

    AI and data analytics growth initiatives Q1 AI revenue / % of FY27 target $14M / 28% AI Revenue (recurring revenue) Total corporate customers for subscription knowledge feeds 23 $49M $50M+ $40M $8M 2-3x Total industry verticals Building traction with AI licensing customers in life sciences, healthca

  9. Slide 9: AI momentum, accelerating

    AI momentum, accelerating Rising value and widening application of our trusted proprietary content, data, and intelligence 1 Demand for our proprietary content and data growing across verticals, products, and channels 2 AI licensing pipeline scaling for model training, commercial licensing, and subs

  10. Slide 10: Wiley activating a very deep and untapped mine of proprietary data

    Wiley activating a very deep and Our content untapped mine of proprietary data advantages Published content Life Sciences and Healthcare Articles, journals, search Leading position in 150+ therapeutic areas; top position in clinical outcome assessments and medical synthesis Chemistry Leading positio

  11. Slide 11: Trusted content and intelligence in demand across a growing number of use cases and markets

    Trusted content and intelligence in demand across a growing number of use cases and markets Subscription Knowledge Feeds Commercial Licensing Clinical Outcome Assessments Examples: Chemistry, life sciences and food science Example: Medical content Example:. Dermatology instruments and agriculture da

  12. Slide 12: Leader in Responsible AI

    Leader in Responsible AI Most companies build responsible AI from the model outward. Responsible AI depends on the quality and trustworthiness of the knowledge that fuels it, and that’s what Wiley has spent two centuries building Human Oversight Trust & Transparency Safety & Fairness Governance We k

  13. Slide 13: Financials

    Financials

  14. Slide 14: Research Segment

    Research Segment Driving strong momentum across key strategic areas and meaningful margin expansion (millions) Q1 2027 Change Change CC Research Publishing $259 12% 12% Research Solutions $34 (31%) (30%) Total Revenue $293 4% 4% Adjusted EBITDA $87 9% 9% Adjusted EBITDA Margin 29.6%* *vs. Adjusted E

  15. Slide 15: Learning Segment

    Learning Segment Q1 performance due to prior year AI comparison and market conditions in Professional; Q1 seasonally light (millions) Q1 2027 Change Change CC Academic $45 (19%) (20%) Professional $48 (19%) (20%) Total Revenue $93 (19%) (20%) Adjusted EBITDA $14 (55%) (56%) Adjusted EBITDA Margin 15

  16. Slide 16: Expanding margins and reinvesting in durable growth

    Expanding margins and reinvesting in durable growth Q1 Update Corporate Expenses* down 19% ▪ Tech transformation: shifting spend from legacy maintenance to product and innovation. Retiring tech debt, consolidating facilities, and scaling our Virtusa partnership $41M ▪ Corporate cost structure: drivi

  17. Slide 17: Disciplined Capital Allocation

    Disciplined Capital Allocation Balancing high-return investments with returning cash to shareholders • Capex of $14M vs. prior year $15M; shifting to growth and product development Q1 Financial Position • Scaling Advanced journal portfolio growing at double digits ▪ Q1 Free Cash Flow use of $70 Orga

  18. Slide 18: Fiscal 2027 Outlook Reaffirmed

    Fiscal 2027 Outlook Reaffirmed Metric Fiscal 2025 Fiscal 2026 Fiscal 2027 Outlook Organic Revenue Growth* Low to mid single digit growth (Research: mid-single digit growth) Adjusted EBITDA Margin 24.0% 26.2% 26.5% to 27.5% Adjusted EPS $3.64 $4.19 $4.60 to $5.05 Free Cash Flow $126M $195M $205M *Org

  19. Slide 19: Executive Summary

    Executive Summary Well on track to deliver mid-single digit growth in Research with strong publishing demand and output, market share gains, and society wins. Long term trends favorable Well on track to deliver on AI revenue goals with $14M of Q1 revenue, expanding pipeline, and widening growth oppo

  20. Slide 20: Wiley's Differentiators in the AI Economy

    Wiley’s Differentiators in the AI Economy Demand is rapidly accelerating for Wiley’s trusted content and intelligence Trusted, continually updating Leading position in high-demand World renowned CONTENT AND DATA KNOWLEDGE DOMAINS TRUST AND REPUTATION Provides access to world’s trusted scientific, Di

  21. Slide 21: Thank you for joining us

    Thank you for joining us Mark your calendar: Fiscal 2027 Investor Day March 11, 2027 For more information or follow-up: investors.wiley.com brian.campbell@wiley.com

  22. Slide 22: Appendix - US GAAP to Non-GAAP Reconciliation

    Appendix - US GAAP to Non-GAAP Reconciliation Reconciliation of US GAAP (Loss) Earnings per Share to Non-GAAP Adjusted EPS Three Months Ended July 31, 2026 2025 US GAAP (Loss) Earnings Per Share - Diluted $ (0.23) $ 0.22 Adjustments: Acquisition and integration related costs 0.20 - Restructuring and

  23. Slide 23: Appendix – Net Income to Adjusted EBITDA

    Appendix – Net Income to Adjusted EBITDA Three Months Ended July 31, 2026 2025 Net (Loss) Income $ (11,727) $ 11,700 Interest expense 13,926 11,042 (Benefit) provision for income taxes (850) 6,007 Depreciation and amortization 37,321 36,446 Non-GAAP EBITDA 38,670 65,195 Acquisition and integration r

John Wiley & Sons — Q1 2027 Earnings Presentation on 6ix